Clean Science FY26 results: PAT falls 14%, ₹4 dividend

Update in focus: multiple board decisions across FY26

Clean Science & Technology Limited disclosed a series of board outcomes through the year under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company’s disclosures covered quarterly and annual financial results, dividends, and corporate actions. A key early FY26 event was the board meeting held on January 31, 2026, for Q3FY26 unaudited results and an interim dividend. Later, the board met on May 14, 2026, to approve audited results for the quarter and financial year ended March 31, 2026. Alongside the FY26 results, the board recommended a final dividend and approved additional investment in its wholly owned subsidiary. The company also announced re-appointments of internal and cost auditors for FY 2026-27. Separately, the company granted employee stock options under ESOS 2021 with a defined vesting schedule.

January 31, 2026: Q3FY26 results and interim dividend

As per the board meeting outcome dated January 31, 2026, the board approved unaudited standalone and consolidated financial results. These results were for the quarter and nine months ended December 31, 2025. The same meeting also declared an interim dividend of ₹2 per equity share (face value ₹1) for FY 2025-26. The company had earlier informed the exchange that the meeting would take up two specific matters: approval of Q3FY26 financial results and consideration of an interim dividend. The regulatory filing date cited for this agenda was January 15, 2026. For the interim dividend, the record date for determining eligible shareholders was fixed as February 6, 2026. The company also stated that trading window restrictions would remain in effect until 48 hours after the results announcement.

May 14, 2026: FY26 audited results approved

Clean Science & Technology later announced its audited standalone and consolidated financial results for the fourth quarter and financial year ended March 31, 2026. At the board meeting held on May 14, 2026, the Board of Directors approved the audited financial results. The disclosures also referred to a scheduled board meeting on May 14, 2026, to review and approve these audited results (as per the company filing referenced in the text). In the same set of updates, Clean Science & Technology reported that FY26 standalone profit after tax (PAT) declined 14% to ₹251 crore. It also reported that FY26 standalone revenue decreased to ₹815 crore. These FY26 numbers were presented as year performance indicators alongside the dividend and investment announcements.

Final dividend recommendation: ₹4 per share for FY26

Along with the FY26 audited results, the board recommended a final dividend of ₹4 per equity share of face value ₹1 each for FY26. The recommendation was stated to be subject to shareholder approval at the ensuing Annual General Meeting. The company also disclosed that the final dividend implied a total payout ratio of 25% for the year. The book closure and dividend payment date were to be determined later. The disclosures repeated the final dividend recommendation in multiple places, aligning it with the May 14, 2026 board approval of audited results. For investors tracking shareholder returns, the FY26 disclosures therefore included both an interim dividend (₹2) and a proposed final dividend (₹4), each tied to separate board approvals.

Subsidiary investment: additional ₹200 crore into Clean Fino-Chem

The board also approved an additional investment of ₹200 crore in Clean Fino-Chem Limited, a wholly owned subsidiary. The investment was approved to be made in one or more tranches. This capital allocation decision was disclosed alongside the FY26 audited results and dividend recommendation. The company did not disclose tranche timing or specific utilisation details in the provided text. Still, the approval indicates continued funding support to the subsidiary through FY26. Investors typically track such approvals to understand cash deployment priorities and group structure investments.

Auditor re-appointments for FY 2026-27

Clean Science & Technology disclosed governance-related approvals as well. The board approved the re-appointment of M/s CNK JBMS & Associates as Internal Auditors for FY 2026-27. It also approved the re-appointment of M/s Dhananjay V. Joshi & Associates as Cost Auditors for FY 2026-27. These re-appointments were stated as part of the board decisions in the May 2026 outcome. Such updates are typically provided under SEBI disclosure requirements as they relate to compliance and oversight processes.

Employee stock option grant: 29,447 options at ₹500

In another corporate update included in the provided text, the company approved issuance of 29,447 stock options under its Employee Stock Option Scheme 2021. The options carry an exercise price of ₹500 per option with a 1:1 conversion ratio (one option to one equity share). The vesting schedule runs over four years from November 2026 to November 2029. The vesting percentages disclosed were 20% each in November 2026, November 2027, and November 2028, and 40% in November 2029. Employees have a one-year window from each vesting date to exercise their vested options. The grant was approved by the Nomination and Remuneration Committee and described as compliant with SEBI regulations for share-based employee benefits.

Key data points at a glance

Market snapshot and context from the provided data

The dataset also included a current share price of ₹802.75. It carried a summary-style scoring strip showing valuation (1/6), future growth (3/6), past performance (2/6), financial health (6/6), and dividends (3/6). A separate performance line showed “-13.60 (-1.29%)” without additional context on the time window. The text also cited a Q2 FY2026 consolidated revenue figure of ₹238 crore with EBITDA margins maintained at 38.2%, presented as a year-on-year increase of 3%. These items, while not a full financial statement, provide reference points alongside the board’s FY26 disclosures on profit, revenue, and dividends.

Why these disclosures matter for investors

For listed companies, board outcomes under Regulation 30 and results under Regulation 33 are key inputs for tracking financial performance and shareholder payouts. In this case, the FY26 standalone PAT decline to ₹251 crore and standalone revenue decrease to ₹815 crore provide the headline financial direction disclosed in the text. The dividend announcements add a second layer, because the board approved an interim dividend in FY26 and recommended a final dividend for FY26, subject to shareholder approval. The subsidiary investment approval of ₹200 crore signals further capital commitment to Clean Fino-Chem. The ESOS grant and vesting schedule are relevant for understanding employee incentives and potential equity issuance over time.

What to watch next

The company stated that book closure and dividend payment dates for the FY26 final dividend would be decided later. Shareholder approval for the final dividend is to be sought at the ensuing Annual General Meeting, as disclosed. Investors will also track how the additional ₹200 crore investment into Clean Fino-Chem is executed across tranches. For the interim dividend, the record date was clearly disclosed as February 6, 2026. Future board outcomes and periodic results disclosures will continue to be important for confirming how FY26 trends carry forward.